During the past decade, Hospital Universitario Central de Asturias conducted 281 clinical trials. In the 10-year time frame, 281 clinical trials started and 73 clinical trials were completed, i.e. on average, 26% percent of trials that started reached the finish line to date. In the past 5 years, 127 clinical trials started and 51 clinical trials were completed. i.e. 40.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Central de Asturias" #1 sponsor was "PETHEMA Foundation" with 43 trials, followed by "Celgene" with 20 trials sponsored, "Hoffmann-La Roche" with 20 trials sponsored, "Spanish Oncology Genito-Urinary Group" with 14 trials sponsored and "Pfizer" with 14 trials sponsored. Other sponsors include 315 different institutions and companies that sponsored additional 200 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Central de Asturias" #1 collaborator was "Bristol-Myers Squibb" with 12 trials as a collaborator, "Apices Soluciones S.L." with 9 trials as a collaborator, "Hospital Universitario Central de Asturias" with 7 trials as a collaborator, "Instituto de Salud Carlos III" with 7 trials as a collaborator and "GlaxoSmithKline" with 6 trials as a collaborator. Other collaborators include 305 different institutions and companies that were collaborators in the rest 250 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Central de Asturias" are "Multiple Myeloma" (15 trials), "Acute Myeloid Leukemia" (9 trials), "Myelodysplastic Syndromes" (8 trials), "Carcinoma, Non-Small-Cell Lung" (7 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "Hospital Universitario Central de Asturias" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Central de Asturias" are "Drug" (280 trials), "Other" (44 trials), "Device" (41 trials), "Procedure" (26 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Dexamethasone" (16 trials), "Cytarabine" (10 trials), "Cyclophosphamide" (9 trials) and "Lenalidomide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Central de Asturias" are 398 trials for "All" genders, 18 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 152 active trials in "Hospital Universitario Central de Asturias". 3 are not yet recruiting, 77 are recruiting, 71 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 206 completed trials in Hospital Universitario Central de Asturias, 2 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Central de Asturias, 21 "Phase 1" clinical trials were conducted, 108 "Phase 2" clinical trials and 143 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 19 trials that are defined as “Not Applicable".